Analyst Ratings for ANI Pharmaceuticals (ANIP)
ANIP Rating Summary
ANIP Price Target Summary
- Highest: $120.00 (Jefferies)
- Lowest: $90.00 (Canaccord)
- Average: $105.29
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$105.29 (+46.4%)
* Over Last 12-Mos
Rating Score: 7.1 / 10
Percentile Rank: 75%
Avg. $ Target:
$105.29 (+46.4%)
* Over Last 12-Mos
Rating Score: 7.1 / 10
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/16/2026 | Canaccord » Updated 8/10/2026 |
Gary Newman | New Coverage | Hold (N/A) |
90.00 (91.00) |
80.82 (71.92) |
-11.01% | Details |
| 7/10/2025 | H.C. Wainwright » Updated 8/11/2025 |
Brandon Folkes | New Coverage | Buy (N/A) |
93.00 (84.00) |
65.31 (71.92) |
10.12% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||


